Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Abiola Ibraheem

TitleInstructor
InstitutionUniversity of Chicago
DepartmentMedicine-Hematology and Oncology
AddressChicago IL 60637
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Anakwenze Akinfenwa CP, Ibraheem A, Nwankwo K, Lasebikan N, Ali-Gombe M, Aliyu UM, Ikhile E, Adegboyega O, Abdullahi A, Klopp AH, Schmeler K, Lin LL, Jhingran A, Page BR, Leng J, Grover S, Ntekim A. Emerging Use of Public-Private Partnerships in Public Radiotherapy Facilities in Nigeria. JCO Glob Oncol. 2021 08; 7:1260-1269. PMID: 34351813.
      View in: PubMed
    2. Ibraheem A, Pillai C, Okoye I, Smith JJ, Reidy-Lagunes D, Macaulay G, Alatise O. Cancer Clinical Trials in Africa-An Untapped Opportunity: Recommendations From AORTIC 2019 Conference Special Interest Group in Clinical Trials. JCO Glob Oncol. 2021 08; 7:1358-1363. PMID: 34506222.
      View in: PubMed
    3. Fatiregun OA, Oluokun T, Lasebikan NN, Nwachukwu E, Ibraheem AA, Olopade O. Breast Cancer Research to Support Evidence-Based Medicine in Nigeria: A Review of the Literature. JCO Glob Oncol. 2021 03; 7:384-390. PMID: 33720754.
      View in: PubMed
    4. Zhao F, Copley B, Niu Q, Liu F, Johnson JA, Sutton T, Khramtsova G, Sveen E, Yoshimatsu TF, Zheng Y, Ibraheem A, Jaskowiak N, Nanda R, Fleming GF, Olopade OI, Huo D. Racial disparities in survival outcomes among breast cancer patients by molecular subtypes. Breast Cancer Res Treat. 2021 Feb; 185(3):841-849. PMID: 33111220.
      View in: PubMed
    5. Ntekim A, Ibraheem A, Adeniyi-Sofoluwe A, Adepoju T, Oluwasanu M, Aniagwu T, Awolude O, Balogun W, Kotila O, Adejumo P, Babalola CP, Arinola G, Ojengbede O, Olopade CO, Olopade OI. Implementing oncology clinical trials in Nigeria: a model for capacity building. BMC Health Serv Res. 2020 Aug 03; 20(1):713. PMID: 32746811.
      View in: PubMed
    6. Ntekim AI, Ibraheem A, Sofoluwe AA, Kotila O, Babalola C, Karrison T, Olopade CO. ARETTA: Assessing Response to Neoadjuvant Taxotere and Subcutaneous Trastuzumab in Nigerian Women With HER2-Positive Breast Cancer: A Study Protocol. JCO Glob Oncol. 2020 07; 6:983-990. PMID: 32628583.
      View in: PubMed
    7. Ibraheem A, Olopade OI, Huo D. Propensity score analysis of the prognostic value of genomic assays for breast cancer in diverse populations using the National Cancer Data Base. Cancer. 2020 09 01; 126(17):4013-4022. PMID: 32521056.
      View in: PubMed
    8. Ibraheem AF, Giurcanu M, Sowunmi AC, Awolude O, Habeebu M, Popoola A, Sanni F, Agaga LA, Olopade O, Polite BN. Formal Assessment of Teamwork Among Cancer Health Care Professionals in Three Large Tertiary Centers in Nigeria. JCO Glob Oncol. 2020 04; 6:560-568. PMID: 32255716.
      View in: PubMed
    9. Leng J, Ntekim AI, Ibraheem A, Anakwenze CP, Golden DW, Olopade OI. Infrastructural Challenges Lead to Delay of Curative Radiotherapy in Nigeria. JCO Glob Oncol. 2020 02; 6:269-276. PMID: 32083951.
      View in: PubMed
    10. Ibraheem AF, Press DJ, Olopade OI, Huo D. Community clinical practice patterns and mortality in patients with intermediate oncotype DX recurrence scores: Who benefits from chemotherapy? Cancer. 2019 01 15; 125(2):213-222. PMID: 30387876.
      View in: PubMed
    11. Szmulewitz RZ, Peer CJ, Ibraheem A, Martinez E, Kozloff MF, Carthon B, Harvey RD, Fishkin P, Yong WP, Chiong E, Nabhan C, Karrison T, Figg WD, Stadler WM, Ratain MJ. Prospective International Randomized Phase II Study of Low-Dose Abiraterone With Food Versus Standard Dose Abiraterone In Castration-Resistant Prostate Cancer. J Clin Oncol. 2018 05 10; 36(14):1389-1395. PMID: 29590007.
      View in: PubMed
    12. Press DJ, Ibraheem A, Dolan ME, Goss KH, Conzen S, Huo D. Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results. Breast Cancer Res Treat. 2018 Feb; 168(1):207-220. PMID: 29181717.
      View in: PubMed
    13. Ibraheem A, Polite B. Improving the accrual of racial and ethnic minority patients in clinical trials: Time to raise the stakes. Cancer. 2017 12 15; 123(24):4752-4756. PMID: 29072791.
      View in: PubMed
    14. Ayoola AO, Ibraheem AF. SIRFLOX: Progression-Free Survival in the Liver As a Surrogate End Point for Survival? J Clin Oncol. 2016 12; 34(34):4193. PMID: 27621405.
      View in: PubMed
    Ibraheem's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (73) concept(s)
    _
    Co-Authors Expand Description
    See all (18) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department
    Physical Neighbors Expand Description
    _